ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MIGUEL RODRIGUEZ MAY MD

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,111Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 1211

$1.74M Total Retail Price of All Prescriptions

Rank: 7 out of 1211

437 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

8% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 15,270 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$96 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
NEXIUM 602 486 1 41
CRESTOR 536 436 2 11
LIDODERM 524 423 3 103
IBUPROFEN 446 377 4 70
ADVAIR DISKUS 439 363 5 84
FUROSEMIDE 356 322 6 7
DIOVAN 351 290 7 21
PLAVIX 344 286 8 14
CLOPIDOGREL 342 288 9 10
OMEPRAZOLE 337 274 10 20
SINGULAIR 332 266 11 102
METFORMIN HCL 325 274 12 27
CELEBREX 318 266 13 124
AMLODIPINE BESYLATE 303 258 14 2
DONEPEZIL HCL 293 268 15 58
VOLTAREN 290 248 16 106
METOPROLOL TARTRATE 262 239 17 4
SIMVASTATIN 259 248 18 1
POTASSIUM CHLORIDE 217 200 19 19
NAMENDA 208 194 20 80
LISINOPRIL 206 176 21 6
TRICOR 202 172 22 82
SURE COMFORT 200 166 23 181
DICLOFENAC SODIUM 193 159 24 117
TRAMADOL HCL 185 156 25 65
LEVOTHYROXINE SODIUM 182 159 26 22
NOVOLIN 70-30 181 148 27 137
CARVEDILOL 177 177 28 3
ZOLPIDEM TARTRATE 171 159 29 32
DIOVAN HCT 170 150 30 35
ESCITALOPRAM OXALATE 167 152 31 89
MONTELUKAST SODIUM 163 128 32 158
METOPROLOL SUCCINATE 156 141 33 5
PROAIR HFA 148 114 34 125
ACTOS 141 107 35 147
MEGESTROL ACETATE 139 131 R 36 128
MECLIZINE HCL 135 111 37 90
TAMSULOSIN HCL 131 129 38 62
INSULIN SYRINGE 129 100 39 126
CYCLOBENZAPRINE HCL 126 94 R 40 173
HYDROCHLOROTHIAZIDE 124 108 41 17
LEXAPRO 123 118 42 138
GABAPENTIN 123 97 42 57
DIGOXIN 121 121 44 15
LYRICA 121 83 44 144
GLYBURIDE-METFORMIN HCL 114 104 R 46 111
DICYCLOMINE HCL 110 90 47 158
RANITIDINE HCL 109 103 48 45
LOVAZA 108 84 49 52
ABILIFY 108 67 49 206
LANTUS 105 77 51 114
ATENOLOL 100 87 52 13
EXELON 100 83 52 172
PENTOXIFYLLINE 96 94 54 152
LOSARTAN POTASSIUM 95 79 55 12
LANSOPRAZOLE 94 84 56 127
GEMFIBROZIL 93 80 57 134
ATORVASTATIN CALCIUM 91 89 58 9
AZITHROMYCIN 86 64 59 63
ALLOPURINOL 82 76 60 59
NAPROXEN 81 62 61 120
CLOTRIMAZOLE-BETAMETHASONE 81 71 61 116
SPIRIVA 80 64 63 151
PAROXETINE HCL 79 76 64 99
SERTRALINE HCL 79 79 64 74
HYDROCODONE-ACETAMINOPHEN 73 44 S3 66 72
GLIPIZIDE 73 62 66 94
SEROQUEL XR 72 60 68 280
KETOCONAZOLE 72 72 68 136
FAMOTIDINE 69 69 70 66
ACTONEL 69 53 70 160
ALENDRONATE SODIUM 69 61 70 60
NASONEX 67 31 73 213
MUPIROCIN 66 54 74 168
TRIAMTERENE-HCTZ 65 56 75 53
FLUTICASONE PROPIONATE 64 54 76 98
AMMONIUM LACTATE 64 53 76 187
COMBIVENT 61 38 78 190
ISOSORBIDE MONONITRATE ER 61 44 78 16
LIPITOR 60 50 80 38
PANTOPRAZOLE SODIUM 59 49 81 44
DEXILANT 59 47 81 149
NITROGLYCERIN PATCH 57 49 83 55
JANUVIA 55 50 84 104
LACTULOSE 54 41 85 155
BENICAR 53 53 86 69
NIFEDIPINE ER 52 52 87 43
CLOBETASOL PROPIONATE 51 51 88 234
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.